Generalization and safety of the second-line levofloxacin or Bismuth-based quadruple therapy for Helicobacter eradication

被引：0
|
作者：
Hu, Bowen [1 ]
Huanfei, Ding [1 ,2 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, 1 Eastern Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2023年 / 46卷 / 11期
关键词：
D O I：
10.1016/j.asjsur.2023.06.082
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：5079 / 5079
页数：1
相关论文
共 50 条
  • [1] Helicobacter pylori Eradication Rates and Related Factors by Second-Line Bismuth-Based Quadruple Therapy
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Lee, Jun Yeob
    Lee, Jin Wook
    Kim, Hae Koo
    Nam, Kyoung Sik
    Nam, Yong Jin
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S881 - S881
  • [2] TREND IN HELICOBACTER PYLORI ERADICATION RATES BY SECOND-LINE BISMUTH-BASED QUADRUPLE THERAPY AND RELATED FACTORS IN ERADICATION THERAPY
    Kim, S.
    Park, M.
    Park, S.
    Moon, W.
    Park, S.
    Jo, J.
    Kim, S.
    [J]. HELICOBACTER, 2015, 20 : 94 - 94
  • [3] Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication
    Hwang, Jae Jin
    Lee, Dong Ho
    Lee, Ae-Ra
    Yoon, Hyuk
    Shin, Cheol Min
    Park, Young Soo
    Kim, Nayoung
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (26) : 8132 - 8139
  • [4] FOURTEEN- VERSUS SEVEN-DAY BISMUTH-BASED QUADRUPLE THERAPY FOR SECOND-LINE HELICOBACTER PYLORI ERADICATION
    Hwang, J.
    Lee, D.
    Yoon, H.
    Shin, C.
    Park, Y.
    Kim, N.
    [J]. HELICOBACTER, 2015, 20 : 93 - 93
  • [5] Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication
    Jae Jin Hwang
    Dong Ho Lee
    Ae-Ra Lee
    Hyuk Yoon
    Cheol Min Shin
    Young Soo Park
    Nayoung Kim
    [J]. World Journal of Gastroenterology, 2015, (26) : 8132 - 8139
  • [6] EFFECTIVENESS AND SAFETY OF MODIFIED BISMUTH-BASED QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
    Marusic, M.
    Majstorovic, K.
    Jurcic, D.
    Bilic, A.
    Bago, J.
    Troskot-Peric, R.
    Halle, Z. Belosic
    Luetic, K.
    Bakula, V.
    Dominkovic, A.
    [J]. HELICOBACTER, 2012, 17 : 104 - 104
  • [7] Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children
    Kotilea, Kallirroi
    Cadranel, Samy
    Salame, Assaad
    Nguyen, Julie
    Mahler, Tania
    Deyi, Veronique Yvette Miendje
    Verset, Laurine
    Bontems, Patrick
    [J]. HELICOBACTER, 2021, 26 (04)
  • [8] Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line
    Simona Di Caro
    Lucia Fini
    Yayha Daoud
    Fabio Grizzi
    Antonio Gasbarrini
    Antonino De Lorenzo
    Laura Di Renzo
    Sara McCartney
    Stuart Bloom
    [J]. World Journal of Gastroenterology, 2012, 18 (40) : 5669 - 5678
  • [9] Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line
    Di Caro, Simona
    Fini, Lucia
    Daoud, Yayha
    Grizzi, Fabio
    Gasbarrini, Antonio
    De Lorenzo, Antonino
    Di Renzo, Laura
    McCartney, Sara
    Bloom, Stuart
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (40) : 5669 - 5678
  • [10] LEVOFLOXACIN/AMOXICILLIN-BASED REGIMENS VERSUS QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN SECOND-LINE: A METANALYSIS
    Di Caro, S.
    Fini, L.
    Daoud, Y.
    Laghi, L.
    Gasbarrini, A.
    Mccartney, S.
    Bloom, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 : S161 - S161
12345